Top Industry Leaders in the Infectious Disease Treatments Market
Latest Infectious Disease Treatments Companies Updates
Pfizer and Gilead remain dominant players: These pharmaceutical giants hold a combined 62% share of the market, driven by their strong portfolios of vaccines and antiviral drugs.
Moderna expands beyond COVID-19: The company announces positive Phase 2 trial results for its cytomegalovirus (CMV) vaccine candidate, potentially setting the stage for a new market entry.
Novartis receives FDA approval for Lutforal (brexafolmab) for invasive aspergillosis: This new antifungal medication offers an alternative treatment option for this serious fungal infection.
Antibiotic development sees renewed focus: Companies like Entasis Therapeutics and Achaogen are developing novel antibiotics against resistant bacteria, addressing a critical unmet need.
PwC Legal LLC: Introduced their PwC CLEAR eDiscovery platform in January 2024, providing a comprehensive eDiscovery solution with built-in data privacy and security features for healthcare clients.
List of Infectious Disease Treatments Key companies in the market:
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc. (U.K)
- AstraZeneca (U.K)
- Novartis AG (Switzerland)
- Sanofi (France)
- Mylan N.V. (U.S.)
